Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Akumin Inc AKUMQ

Akumin Inc. is a provider of radiology and oncology services to health systems, hospitals, physician groups, and patients all across the country. The Company operates through two segments: Radiology and Oncology. The Company provides fixed-site outpatient diagnostic imaging services through a network of approximately 180 owned and/or operated imaging locations, and outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 48 states. Its imaging procedures include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. Its services include radiology exams, radiology technology, radiology subspecialties, oncology conditions treated and oncology radiation therapy.


OTCPK:AKUMQ - Post by User

Comment by mjh9413on Sep 02, 2021 12:23am
358 Views
Post# 33799431

RE:RE:Well...Regardless

RE:RE:Well...RegardlessOK I felt same way. Now we have the deal closed and expectation of around $750,000,000 of annual revs but it comes with a lot of finance costs.They already paid about $8MM/qtr on the 2025 Notes and about a total $0.9MM on the Wesley Chapel loan and commitment fee on the $55MM revolver. Now we can add ~$10.3MM to Stonepeak, ~$7MM on the new Senior Notes, total US$26MM/qtr. Plus there are high lease liabilities and interest costs.
Now we have to see how they apportion the acquisition costs and how much goodwill is added to the balance sheet...and will it ever be tax deductible?! 
What I do like is the size and breadth of the new company and I see prospect that Stonepeak wants them getting even larger share of market for these services, through further acquisition...don't know if antitrust competition rules might ever kick in.
I also like, as I said before, the Alliance people overseeing the whole company.
The number of shares might have increased only a little at acqun but those 30MM+/US$2.98 warrants...let's hope they are 'cheap.'
The obvious winners are Thailot (the price they got) and Stonepeak at this point (that 11% loan and payout options, well, they're outrageous, but how else would it have got done?)
The lenders must feel the financial adjustments will not be too material...let's hope so.
With all said I do not see AKU share price moving too much ahead short term. Look forward to post acqun financials and re-rating...UP.
GL
<< Previous
Bullboard Posts
Next >>